Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Wattanapitayakul

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|April 24, 2001
Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implicationsS K Wattanapitayakul, J A Bauer
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 29, 2000
Recent developments in gene therapy for cardiac diseaseS K Wattanapitayakul, J A Bauer
Evidence-Based Complementary and Alternative Medicine : Ecam|February 13, 2013
Pummelo protects Doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescenceL Chularojmontri, O Gerdprasert, S K Wattanapitayakul
Trends in Pharmacological Sciences|June 30, 2001
Therapeutic implications of human endothelial nitric oxide synthase gene polymorphismS K Wattanapitayakul, M J Mihm, A P Young, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2000
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disordersS K Wattanapitayakul, D M Weinstein, B J Holycross, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|April 24, 2001
Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implicationsS K Wattanapitayakul, J A Bauer
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 29, 2000
Recent developments in gene therapy for cardiac diseaseS K Wattanapitayakul, J A Bauer
Evidence-Based Complementary and Alternative Medicine : Ecam|February 13, 2013
Pummelo protects Doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescenceL Chularojmontri, O Gerdprasert, S K Wattanapitayakul
Trends in Pharmacological Sciences|June 30, 2001
Therapeutic implications of human endothelial nitric oxide synthase gene polymorphismS K Wattanapitayakul, M J Mihm, A P Young, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2000
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disordersS K Wattanapitayakul, D M Weinstein, B J Holycross, et al.
Pageof 1